Back
Coca-Cola FEMSA SAB de CV Vs. Nektar Therapeutics Industry Stock Comparison
Buy
52
KOF
Coca-Cola FEMSA SAB de CV
Last Price:
$91.41
Seasonality Move:
3.35%
Sell
42
NKTR
Nektar Therapeutics
Last Price:
$44.63
Seasonality Move:
11.58%
Buy
52
Coca-Cola FEMSA SAB de CV (KOF)
is a Buy
Is Coca-Cola FEMSA SAB de CV a Buy, Sell or Hold?
-
The current Coca-Cola FEMSA SAB de CV [KOF] share price is $92.58. The Score for KOF is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
KOF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KOF Stock Price Chart
What is Coca-Cola FEMSA SAB de CV's stock price today?
-
The Coca-Cola FEMSA SAB de CV share price today is $92.58The current trend is moderately bullish and KOF is experiencing slight selling pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $49.16Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.
KOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.61 | Buy |
| Relative Strength Index (14 RSI): | 61.93 | Buy |
| Chaikin Money Flow: | -28881 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.43 | Sell |
| Relative Strength Index (14 RSI): | 38.92 | Sell |
| Chaikin Money Flow: | 341847 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
KOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 92.3 | Buy |
| 20-day SMA: | 89.8 | Buy |
| 50-day SMA: | 87.47 | Buy |
| 200-day SMA: | 89.38 | Buy |
| 8-day EMA: | 92.2 | Buy |
| 20-day EMA: | 90.52 | Buy |
| 50-day EMA: | 88.47 | Buy |
| 200-day EMA: | 87.68 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.87 | Sell |
| 20-day SMA: | 57.43 | Sell |
| 50-day SMA: | 58.05 | Sell |
| 200-day SMA: | 31.04 | Buy |
| 8-day EMA: | 54.11 | Sell |
| 20-day EMA: | 56.28 | Sell |
| 50-day EMA: | 55.42 | Sell |
| 200-day EMA: | 38.13 | Buy |
Coca-Cola FEMSA SAB de CV Earnings Growth & KOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.92 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.
Coca-Cola FEMSA SAB de CV Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||